SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18818921
Source:
http://linkedlifedata.com/resource/pubmed/id/18818921
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008838
,
umls-concept:C0205179
,
umls-concept:C0205420
,
umls-concept:C0246415
,
umls-concept:C0332174
,
umls-concept:C0441771
,
umls-concept:C0684249
,
umls-concept:C0817096
,
umls-concept:C1517927
,
umls-concept:C1522449
pubmed:issue
6
pubmed:dateCreated
2009-3-30
pubmed:abstractText
Our objective was to assess the efficacy and toxicity of concurrent chemoradiotherapy with cisplatin + weekly divided-dose docetaxel in patients with stage III non-small-cell lung cancer (NSCLC).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7806519
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids
,
http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1432-0843
pubmed:author
pubmed-author:GomiKotaroK
,
pubmed-author:HayasakaMuneharaM
,
pubmed-author:KoizumiTomonobuT
,
pubmed-author:KuboKeishiK
,
pubmed-author:NakamuraMasaruM
,
pubmed-author:ShikamaNaotoN
,
pubmed-author:TsushimaKenjiK
,
pubmed-author:YasuoMasanoriM
pubmed:issnType
Electronic
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1091-6
pubmed:meshHeading
pubmed-meshheading:18818921-Aged
,
pubmed-meshheading:18818921-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:18818921-Carcinoma, Non-Small-Cell Lung
,
pubmed-meshheading:18818921-Cisplatin
,
pubmed-meshheading:18818921-Combined Modality Therapy
,
pubmed-meshheading:18818921-Disease-Free Survival
,
pubmed-meshheading:18818921-Drug Administration Schedule
,
pubmed-meshheading:18818921-Female
,
pubmed-meshheading:18818921-Humans
,
pubmed-meshheading:18818921-Lung Neoplasms
,
pubmed-meshheading:18818921-Male
,
pubmed-meshheading:18818921-Middle Aged
,
pubmed-meshheading:18818921-Neoplasm Invasiveness
,
pubmed-meshheading:18818921-Neoplasm Staging
,
pubmed-meshheading:18818921-Radiation Dosage
,
pubmed-meshheading:18818921-Taxoids
,
pubmed-meshheading:18818921-Thorax
pubmed:year
2009
pubmed:articleTitle
Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer.
pubmed:affiliation
First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1 Asahi Matsumoto, Nagano, 390-8621, Japan.
pubmed:publicationType
Journal Article
,
Clinical Trial